Every good research story starts with a strange little clue that scientists can't ignore. This one starts with a question: What if a fungus's greatest strength was also its biggest weakness?
The fungus is Candida; most people have encountered it in some form, even without knowing its name. It causes oral thrush, vaginal infections, and, in very sick hospital patients, dangerous blood infections. It's common, tough, and getting harder to treat as drug resistance grows.
Here's the clue that started it all: this fungus wears a kind of armour. Inside is a strong fibre mesh that holds its shape. Outside is a protein coat covered in sugar, plus special "hook" proteins it uses to grab onto human cells and become dangerous. This armour helps Candida cling to tissue, evade the immune system, and build slimy, drug-resistant biofilms that make infections notoriously difficult to treat. The key to breaking this defence is to target the very proteins that build and maintain this protective armour. And we found a potential target, α-glucosidase, a protein that processes mannoproteins, which are essential for extending the cell wall and building biofilms.
Catching a Fungus by Its Sweet Tooth
Instead of building a brand-new drug from scratch, which takes years and huge amounts of money, we asked a smarter question: Does a drug that blocks this protein already exist, even for something totally unrelated? So, we tested over a hundred approved drugs to find out.
One stood out: acarbose, an old diabetes pill. It's normally used to slow down sugar absorption in the gut. Turns out, it blocks a very similar target, just in a totally different context. Finding this was the big surprise: a diabetes drug moonlighting as a fungus fighter.
But here's the twist, acarbose didn't kill the fungus. It kept growing just fine. Instead, it stripped away its weapons: it couldn't become invasive, couldn't form biofilms, and couldn't adhere to or invade human cells. That was the real breakthrough. This wasn't a fungus-killer but a fungus-disarmer, removing its ability to cause harm without pressuring it to fight back and develop resistance, which is what usually happens with killing drugs.
Disarm, Then Finish the Job
A drug that just disarms the enemy isn't a cure by itself. So, the next step was pairing acarbose with a real antifungal: fluconazole, one of the most common antifungal drugs, though it's losing effectiveness due to resistance.
The combo worked far better than we expected. Even in smaller doses, acarbose made fluconazole hit much harder. Together they wiped out far more fungal cells than either could alone, and the fungus didn't recover. Under the microscope, this pairing completely prevented the fungus from forming invasive hyphae, and it didn't regrow even hours later. It also broke down tough, mature biofilms and the effect held up against several other Candida species too.
Building a Smart Gel
Finding two drugs that work well together in a lab is only half the job. Getting them to stay exactly where they're needed, especially for vaginal infections, where gels and creams often leak out or feel uncomfortable, is a whole separate challenge.
So next we focused on a gel that's liquid when applied, but firms up once it warms to body temperature, so it stays in place. After testing 18 different versions, one recipe won: it set at just the right temperature, released both drugs slowly over two days instead of all at once, and stayed stable for months.
The best part? It left the vagina's natural "good bacteria" (Lactobacillus) completely untouched. That matters a lot, because wiping out these protective bacteria is often exactly why infections come back. This gel targets only the fungus.
What Happens Next
This whole project followed a great arc: spot a weakness, discover a surprising drug that exploits it, pair it with something stronger, then build a smart way to deliver it. There's still a way to go, preclinical studies, then human trials, before doctors can actually prescribe it.
But the best part of this story? An old, forgotten diabetes pill, repurposed through pure curiosity about shared biochemistry, might end up protecting the very microbes that keep people healthy. That's the kind of full-circle ending that makes years of lab work feel worth it.
References
- David, H., Vasudevan, S. & Solomon, A.P. Mitigating candidiasis with acarbose by targeting Candida albicansα-glucosidase: in-silico, in-vitro and transcriptomic approaches. Sci Rep 14, 11890 (2024). https://doi.org/10.1038/s41598-024-62684-x
- David, H., Balu, P., Vasudevan, S. et al.Thermoresponsive carbohydrate polymer mucoadhesive gel for synergistic delivery of acarbose and fluconazole against Candida Sci Rep 16, 20543 (2026). https://doi.org/10.1038/s41598-026-52764-5